We present three small biotech stocks, which according to Wall Street analysts, have upside potential for 2025.

Investing in biotech stocks usually isn't for the faint of heart. These stocks tend to be highly volatile because of the ...

Argus downgraded Moderna (MRNA) to Hold from Buy without a price target The firm sees limited upside for the stock over the next 12 months as ...

Moderna 's ( MRNA 3.13%) wild success in the COVID-19 vaccine market has worn off. The company's revenue, earnings, and stock ...

Bird flu has emerged as a critical public health concern in California, with Governor Gavin Newsom declaring a state of ...

After falling off their perch in the last few months of 2024, European healthcare stocks head into a new year facing the ...

Despite being a pioneer in developing one of the first and most widely used COVID-19 vaccines, shares of Moderna MRNA have ...

Novavax (NVAX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock. Pfizer stock and other vaccine shares tumbled Friday ...

Novavax (NVAX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock. Pfizer stock and other vaccine shares tumbled Friday morning ...

Thermo Fisher perfectly rode the tidal wave of demand for health care that came during the pandemic. The company experienced ...

Lilly investors got the jitters, saw better opportunities elsewhere, or decided to hold onto their chips. In the third ...